Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b85b68ef371ec9c8ce0c97811ea032a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
filingDate |
2018-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42bc14b348e497d3103486e4793cfa05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd1caf605df3f5cd34787f68516da66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40480fb0a7c504ac95f49e9e39461faf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8af62bf839a3c2c954967e8fab2a3c |
publicationDate |
2019-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201908340-A |
titleOfInvention |
Modified bispecific polypeptide molecule |
abstract |
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain, which provide a T cell receptor (TCR) derived from a major histocompatibility complex (MHC) related peptide epitope ), A binding region derived from an antibody capable of recruiting human immune effector cells by specifically binding to the cell surface antigen, and a method for preparing a bispecific polypeptide molecule and use thereof. |
priorityDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |